A prescription is filled, adjudicated, and paid by the PBM, and the patient never returns for it. The pharmacy's own point-of-sale system eventually returns the drug to stock, but the paid claim is never reversed to match. When a PBM audit pulls that claim, the finding is a paid claim with no proof the drug ever reached a patient, and it becomes a recoupment demand. The exposure is preventable, provided the pharmacy's reversal process and its timing log keep pace with the will-call bin.
The Return-to-Stock Finding in a PBM Audit
The finding begins with ordinary pharmacy workflow, not fraud. A pharmacy management system submits the claim at the point the prescription is filled, not the point a patient picks it up, so the claim is paid before the pharmacy knows whether the patient will return for it. When a prescription sits in the will-call bin past the pharmacy's own return-to-stock window, the drug goes back into inventory, and the claim should be reversed to show it was never dispensed; CVS Caremark's manual, for example, requires the reversal within fourteen days of the fill date. A PBM auditor comparing the pharmacy's dispensing log, signature log, and point-of-sale reversal history against the original paid claim can isolate exactly which fills were billed but never picked up, and each one becomes a line item in the audit's proposed recoupment.
Why an Unreversed Claim Draws a Full Recoupment
A PBM treats an unreversed return-to-stock claim the same way it treats a claim with no signature on file: as billing for a drug that was never delivered to the patient. Reversing the claim late, after the audit notice rather than before it, does not cure the finding: under CVS Caremark's manual, for example, a pharmacy must not attempt to reverse a claim once on notice of an audit; a reversal entered after that point can itself be evidence of fraud, waste, or abuse, and Caremark performs the reversal itself once the audit concludes. Pharmacies already managing a payment hold face compounding pressure, because an unresolved return-to-stock finding can leave that hold open longer, and a PBM is not required to volunteer when the hold will end (see Payment Holds During a PBM Audit). A pattern of unreversed return-to-stock claims can also become part of the record a PBM cites when it moves toward network termination for cause, so the finding carries weight well beyond the dollar amount of the sample claims themselves.
The Reversal Process and Timing Log That Protect the Pharmacy
The record that defends a return-to-stock claim is built before the audit, not after it. A written policy naming who checks the will-call bin, how often, and when a prescription is pulled and returned to inventory gives the pharmacy a consistent practice to point to. The stronger record is a timing log, a contemporaneous entry capturing the date the drug was returned to stock, the date the claim was reversed, and the employee who performed each step, tied to the original prescription and claim number. Pharmacies that treat accurate reversal timing with the same discipline as their annual fraud, waste, and abuse attestations tend to catch a lapsed will-call bin before an auditor does, not after (see PBM Annual Attestations and FWA Training: Signing Accurately).
What Records Show a Claim Was Reversed or the Drug Restocked
Four records carry the most weight in a return-to-stock dispute. The claim adjudication log should show a reversal transaction tied to the original claim number and dated at or before the pharmacy's own return-to-stock window closed. The point-of-sale system's will-call removal log should show when the prescription left the bin. The inventory management system should show the drug restocked at a matching quantity and date. And a perpetual inventory reconciliation, run on a regular schedule rather than assembled for the audit, corroborates all three. Assembling that record now is also what an audit appeal depends on later, since the appeal reviews the same documentation the original response relied on, and arbitration is the backstop when the appeal does not resolve the dispute (see PBM Arbitration Clauses: Where Your Dispute Actually Goes).
The record that defends a return-to-stock claim is written before the audit begins, in the will-call log and the reversal timestamp, not assembled afterward to explain it.
Why Early Legal Counsel Is Critical
It is critical that pharmacy owners promptly retain experienced healthcare defense counsel upon receiving a PBM audit notice, preliminary findings letter, or any related inquiry. Early legal intervention can protect the pharmacy's rights, ensure appropriate responses to audit requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the PBM on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience. If your pharmacy is facing a return-to-stock finding or any other PBM audit recoupment demand, contact us for a free, confidential consultation and put an attorney between your pharmacy and the PBM before the next deadline runs.
